VUNO, View the Invisible, Know the Unknown
VUNO’s AI solutions are reshaping the medical industry presenting a whole new level of experience to medical practitioners in their day-to-day workflow.
VUNO's AI-based solution for Brain MRI Diagnostics - VUNO
VUNO Med ®-DeepBrain™ AI-based brain atrophy and small vessel disease quantification solution
VUNO's AI-based solution for Brain MRI Diagnostics - VUNO
VUNO stands as a global frontrunner in the realm of medical AI, boasting a compelling history of developing and successfully commercializing cutting-edge deep learning medical AI solutions that help professionals save time, reduce costs, and improve outcomes.
VUNO Secures FDA 510(k) Clearance for VUNO Med® …
SEOUL, South Korea, Oct. 23, 2023 /PRNewswire/ -- VUNO Inc., South Korean medical AI company has received 510(k) clearance from the Food and Drug Administration (FDA) for its AI-powered brain ...
AI brain imaging device receives FDA clearance - Health Imaging
South Korean startup Vuno’s AI-powered brain imaging device has received the 510(k) certification from the U.S. Food and Drug Administration (FDA), signaling the company’s expansion into U.S. markets where it hopes to improve the early diagnosis of dementia.
AI-Based Brain Volumetric Software, VUNO Med-DeepBrain, …
2023年10月31日 · VUNO Med-DeepBrain is an artificial intelligence (AI)-based software that extracts quantitative data of the brain from MRI scans. The software uses brain parcellation to provide volumetric data on multiple brain regions, while also evaluating white matter hyperintensity (WMH) and cortical thickness.
FDA clears artificial intelligence-based MRI assistant from South ...
2023年10月24日 · The U.S. Food and Drug Administration has cleared a new artificial intelligence tool that aids in the acquisition of magnetic resonance images, Seoul, South Korea-based developer Vuno announced Monday.
FDA clears VUNO’s AI software for MRI brain scans
2023年10月24日 · The US Food and Drug Administration (FDA) has cleared VUNO’s Med-DeepBrain, an artificial intelligence (AI) tool that characterises brain structures from magnetic resonance imaging (MRI) scans.
Vuno Gains Clearance for AI-Powered Brain Quantification Device
2023年10月23日 · VUNO, South Korean medical AI company, has received 510(k) clearance from the Food and Drug Administration (FDA) for its AI-powered brain quantification device, VUNO Med-DeepBrain. VUNO Med-DeepBrain is intended to automate the current manual process of identifying, labeling, and quantifying segmentable brain structures from MRI images.
VUNO Inks Deal with Samsung Electronics to Embed AI …
2021年6月25日 · VUNO’s road-tested, clinically-proven chest X-ray detection software is reshaping the delivery of medical imaging diagnostics by being fully integrated with Samsung Electronics’ X-ray system